Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2014
Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancerJ A Pérez-Fidalgo, B Bermejo, I Chirivella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2019
Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinomaV Gambardella, T Fleitas, N Tarazona, et al.
ESMO Open|January 21, 2021
Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancerA Adam-Artigues, I Garrido-Cano, S Simón, et al.
ESMO Open|December 22, 2024
HER2DX genomic test in early-stage HER2-positive breast cancerS M Tolaney, N Tung, A C Wolff, et al.
ESMO Open|September 25, 2025
Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterationsV Seguí, J A Carbonell-Asins, J Martín-Arana, et al.
Nature Communications|December 8, 2022
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin AS Mouron, M J Bueno, A Lluch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative studyM Oliveira, C Falato, J M Cejalvo, et al.
ESMO Open|May 11, 2026
Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE ProjectR Sánchez-Bayona, J de Nicolás-Hernández, C Saura, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world studyO Martínez-Sáez, M Tapia, M Marín-Aguilera, et al.
Pageof 1